Jim Simons Opgen Inc Transaction History

Renaissance Technologies LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.12 - $62.0 $6,708 - $3.47 Million	55,900 Added 47.57%	173,400 $24,000
Q3 2022 Nov 14, 2022	SELL	$0.39 - $78.8 $224,522 - $45.4 Million	-575,698 Reduced 83.05%	117,500 $34,000
Q2 2022 Aug 12, 2022	SELL	$0.32 - $0.79 $140,338 - $346,460	-438,558 Reduced 38.75%	693,198 $378,000
Q1 2022 May 13, 2022	SELL	$0.72 - $1.11 $406,903 - $627,309	-565,144 Reduced 33.3%	1,131,756 $849,000
Q4 2021 Feb 11, 2022	BUY	$1.0 - $2.94 $1.55 Million - $4.54 Million	1,545,400 Added 1020.07%	1,696,900 $1.7 Million
Q3 2021 Nov 12, 2021	BUY	$2.18 - $3.58 $141,148 - $231,794	64,747 Added 74.63%	151,500 $436,000
Q2 2021 Aug 13, 2021	BUY	$1.95 - $2.8 $141,088 - $202,588	72,353 Added 502.45%	86,753 $197,000
Q1 2021 May 13, 2021	BUY	$1.8 - $3.55 $25,920 - $51,120	14,400 New	14,400 $36,000
Q1 2020 May 14, 2020	SELL	$1.14 - $4.04 $77,734 - $275,479	-68,188 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$1.02 - $7.18 $52,523 - $369,726	51,494 Added 308.46%	68,188 $77,000
Q3 2019 Nov 13, 2019	BUY	$4.9 - $8.02 $81,800 - $133,885	16,694 New	16,694 $118,000

Ticker OPGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,698,500
Market Cap $91.3M
Description
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.